The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his ...
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources ...
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over ...
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial ...
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study ...
The Institut Pasteur contributes to the discovery of new treatments for diseases with priority given to the fight against the persistence of infectious risk and the occurrence of emerging diseases. We are also involved in immunology, cancer and neuroscience. To speed up the transfer of basic research to future medical breakthroughs we seek to establish collaboration agreements and co-development partnershipswith exclusive industrial property benefits for our partners.
List of invention disclosures available by therapeutic area
Viral polypeptide inducing neuron survival and regeneration, polynucleotides encoding them and therapeutic uses thereof
ADAM12 as an inflammation marker
Structural variants of mycolactone for use in modulating inflammation
A cocktail of two blocking antibodies, targeting human anti-hFgcR mAbs to treat rheumatoid arthritis, inflammation and/or allergic shock
Structural variants of mycolactone for use in modulating pain
Inhibitors of NAD kinase acting on S. aureus and related Gram + bacteria
Optineurin-derived polypeptides, their nucleic acids and uses thereof
in particular uses in treating cancer(s) or in treating a disease involving mitosis deregulation(s) or alteration(s)